Diagnostic value of daily fluctuations in the free form of testosterone and cortisol in men with obesity and metabolic syndrome under the age of 50 years

The important pathogenetic link of obesity and metabolic syndrome (MS) in men are disorders of testosterone production in the testes and adrenal adrenal cortisol production. Тestosterone deficiency and functional hypercortisolism have a mutual influence on each other. Comprehensive assessment of testosterone and cortisol balance and identify their daily variability in the saliva may improve the diagnosis of hormonal disorders in men with obesity and MS. In the present study, by comparative and correlation analysis assessed the circadian rhythm of cortisol and testosterone production in young and middle age men, finding the relationship between the concentration of these hormones in the morning and evening portions of saliva with the changes of anthropometric, hemodynamic and metabolic parameters. The study involved 35 patients with MS, 16 – with overweight and obesity without the MS and 19 – with normal body weight. In men with obesity and MS found a violation of the circadian rhythm of testosterone production. Evening saliva testosterone showed a close correlation with the parameters of the MSome and clinical symptoms of androgen deficiency, as well as a more pronounced decrease with age. Circadian rhythm of cortisol production was not violated, but cortisol was significantly increased in the evening portion of saliva in patients with obesity and MS. MS was associated not only with an increase in the concentration of free salivary cortisol in the evening hours, but with lower cortisol levels in the batch of saliva collected in the morning, which is consistent with other studies.

1. Stanworth R. D., Jones T. H. Testosterone in obesity, metabolic syndrome and type 2 diabetes. Front Horm Res 2009;37:74–90.

2. Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol 2009;5(12):673–81.

3. Muraleedharan V., Jones T. H. Testosterone and the metabolic syndrome. Ther Adv Endocrinol Metab 2010;1(5):207–23.

4. Goncharov N. P., Katsya G. V., Chagina N. A., Gooren L. J. Testosterone and obesity in men under the age of 40 years. Andrologia 2009;41(2):76–83.

5. Дзеранова Л. К., Панкратова Ю. В., Белая Ж. Е. и др. Гиперкортицизм и метаболический синдром: сложности дифференциальной диагностики и лечения. Ожирение и метаболизм 2012;9(2):57–61. [Dzeranovа L. K., Pankratovа Yu. V., Belaya Zh. Е. et al. Hypercorticoidism and metabolic syndrome: difficulties of the differential diagnostics and treatment. Ozhirenie i metabolism = Adiposity and Metabolism 2012;9(2):57–61. (In Russ.)].

6. Salehi M., Ferenczi A., Zumoff B. Obesity and cortisol status. Horm Metab Res 2005;37(4):193–7.

7. Гончаров Н. П., Колесникова Г. С. Кортикостероиды: метаболизм, механизмы действия и клиническое применение. М.: Адамантъ, 2002. 180 с. [Goncharov N. P., Kolesnikovа G. S. Corticosteroids: metabolism, mechanisms of action and clinical application. Мoscow: Аdamant, 2002. 180 p. (In Russ.)].

8. Viau V. Functional cross-talk between the hypothalamic-pituitary-gonadal and-adrenal axes. J Neuroendocrinol 2002;14(6):506–13.

9. Rubinow D. R., Roca C. A., Schmidt P. J. et al. Testosterone suppression of CRH-stimulated cortisol in men. Neuropsychopharmacology 2005;30(10):1906–12.

10. Лапшина А. М., Марова Е. И., Гончаров Н. П. и др. Исследование свободного кортизола в слюне для оценки функции коры надпочечников. Проблемы эндокринологии 2004;54(2):22–7. [Lapshinа А. М., Маrovа Е. I., Goncharov N. P. et al. Examination of the free cortisone in the saliva for the evaluation of the suprarenal cortex function. Problemy endokrinologii = Problems of Endocrinology 2004;54(2):22–7. (In Russ.)].

11. Гончаров Н. П., Кация Г. В., Добрачева А. Д. и др. Свободный тестостерон в слюне как диагностический маркер андрогенного статуса мужчин. Андрология и генитальная хирургия 2006;(3):32–8. [Goncharov N. P., Katsiya G. V., Dobrachevа А. D. et al. Free testosterone in saliva as diagnostic marker of men’s androgenic status. Andrologiya i genital’naya khirurgiya = Аndrology and Genital Surgery 2006;(3):32–8. (In Russ.)].

12. Goncharov N., Katsya G., Dobracheva A. et al. Diagnostic significance of free salivary testosterone measurement using a direct luminescence immunoassay in healthy men and in patients with disorders of androgenic status. Aging Male 2006;9(2):111–22.

13. Morley J. E., Perry H. M., Patrick P. et al. Validation of salivary testosterone as a screening test for male hypogonadism. Aging Male 2006;9(3):165–9.

14. Alberti K. G., Eckel R. H., Grundy S. M. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120(16):1640–5.

15. Jang Y. M., Lee E. J., Kim D. L. et al. The association between midnight salivary cortisol and metabolic syndrome in Korean adults. Diabetes Metab J 2012;36(3):245–50.

16. Ceccato F., Barbot M., Zilio M. et al. Age and the metabolic syndrome affect salivary cortisol rhythm: data from a community sample. Hormones (Athens) 2015;14(3):392–8.

17. DeSantis A.S., DiezRoux A.V., Hajat A. et al. Associations of salivary cortisol levels with metabolic syndrome and its components: the multi-ethnic study of atherosclerosis. J Clin Endocrinol Metab 2011;96(11):3483–92.